Pharma and Biotech
Total Voting Rights | 30-May-2025 | 14:24 | RNS |
Confirmation of European ODD for NXP002 | 29-May-2025 | 07:00 | RNS |
Publication of a Prospectus | 23-May-2025 | 13:08 | RNS |
£210,000 Placing | 22-May-2025 | 07:00 | RNS |
Half-year Report | 02-May-2025 | 07:00 | RNS |
Confirmation of European Orphan Drug Designation | 30-Apr-2025 | 07:00 | RNS |
Change of Registered Office and Company Secretary | 29-Apr-2025 | 07:00 | RNS |
Exercise of Warrants | 14-Apr-2025 | 07:00 | RNS |
NXP002 Update | 09-Apr-2025 | 07:00 | RNS |
Result of AGM | 20-Mar-2025 | 11:10 | RNS |
Total Voting Rights | 28-Feb-2025 | 12:30 | RNS |
Posting of Annual Report and Notice of AGM | 14-Feb-2025 | 14:18 | RNS |
£168,750 Placing | 30-Jan-2025 | 07:00 | RNS |
Annual Results for period ended 30 September 2024 | 29-Jan-2025 | 07:00 | RNS |
NXP002 ODD Application Submitted | 28-Jan-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.085p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 0.20 |
52 Week Low | 0.048 |
Volume | 91,848,711 |
Shares Issued | 1,995.71m |
Market Cap | £1.70m |
Beta | 0.08 |
RiskGrade | 322 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
14:27 | 2,211 @ 0.090p |
12:50 | 1,939,549 @ 0.087p |
12:14 | 559,470 @ 0.087p |
11:09 | 2,000,000 @ 0.083p |
11:00 | 820,739 @ 0.090p |
You are here: research